Factors negatively affecting a migraine-friendly workplace in healthcare
Abstract
Objectives. This study aimed to assess migraine prevalence among healthcare workers, identify work-related productivity loss and determine the need for a migraine-friendly workplace. Methods. An online survey was conducted among employees from 18 hospitals in a healthcare group, using a three-question ID-migraine test for diagnosis. Data collection was conducted between October and November 2023. The survey collected sociodemographic data, migraine characteristics, most bothersome symptoms, migraine disability assessment scale (MIDAS) scores, and work productivity and activity impairment (WPAI) data. The survey also inquired about workplace factors that worsen migraines. Results. The study included 666 participants, 366 (54.9%) diagnosed with migraine. Participants experienced a mean of 7.44 (SD 6.06) headache days per month, with 51.9% reporting severe headache intensity. Severe MIDAS scores were found in 47% (n = 172). WPAI scores were mean (SD) 4.71% (11.07) for absenteeism, 50.97% (25.53) for presenteeism, 52.24% (25.89) for overall work productivity loss and 55.07% (27.16) for non-work-related activity impairment. The most bothersome symptom was photophobia (43.2%). Common workplace migraine triggers included lighting conditions (79.5%), inadequate rest environments (70.4%) and prolonged screen exposure (69.6%). Conclusions. Improving lighting, creating comfortable rest areas, reducing screen time, shortening hours and lightening workloads could reduce productivity loss…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 666 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.